• Guideline Summary
  • NGC:009868
  • 2012 Jun 15

The role of liver resection in colorectal cancer metastases.

  • Guideline Summary
  • NGC:010545
  • 2012 Aug

SonoVue (sulphur hexafluoride microbubbles) – contrast agent for contrast-enhanced ultrasound imaging of the liver.

  • Guideline Summary
  • NGC:010777
  • 2015 Jul 22

Everolimus for preventing organ rejection in liver transplantation.

  • Guideline Summary
  • NGC:011021
  • 2016 Jul 6

Non-alcoholic fatty liver disease (NAFLD): assessment and management.

  • Guideline Summary
  • NGC:009150
  • 2002 (revised 2012 Jun)

The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association.

  • Guideline Summary
  • NGC:010448
  • 1998 (revised 2014)

ACR Appropriateness Criteria® liver lesion — initial characterization.

  • Guideline Summary
  • NGC:009890
  • 2013 Jan

Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation.

  • Guideline Summary
  • NGC:009072
  • 2012 Apr

Boceprevir for the treatment of genotype 1 chronic hepatitis C.

Cirrhosis in over 16s: assessment and management.

  • Guideline Summary
  • NGC:009076
  • 2012 Apr

Telaprevir for the treatment of genotype 1 chronic hepatitis C.

  • Guideline Summary
  • NGC:010464
  • 2007 (revised 2014)

ACR Appropriateness Criteria® rectal cancer--metastatic disease at presentation.

  • Guideline Summary
  • NGC:011032
  • 2016

ACR Appropriateness Criteria® pretreatment staging of colorectal cancer.

Management of hepatitis C. A national clinical guideline.

  • Guideline Summary
  • NGC:009796
  • 1998 Jan (revised 2013 Feb)

Management of adult patients with ascites due to cirrhosis: update 2012.

  • Guideline Summary
  • NGC:009319
  • 2012 Aug 17

Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945–1965.